Thierry Jolas

1.4k total citations
24 papers, 1.2k citations indexed

About

Thierry Jolas is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Thierry Jolas has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Thierry Jolas's work include Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Receptor Mechanisms and Signaling (7 papers). Thierry Jolas is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Receptor Mechanisms and Signaling (7 papers). Thierry Jolas collaborates with scholars based in United States, France and Spain. Thierry Jolas's co-authors include George K. Aghajanian, Rongjian Liu, M. Hamon, J. Adrien, Laurence Lanfumey, Samir Haj‐Dahmane, L. David Waterbury, Eric J. Nestler, Anne‐Marie Laporte and H. Gozlan and has published in prestigious journals such as Biological Psychiatry, Brain Research and Neuroscience.

In The Last Decade

Thierry Jolas

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Jolas United States 18 849 488 240 222 169 24 1.2k
B B Wolfe United States 14 845 1.0× 782 1.6× 192 0.8× 162 0.7× 117 0.7× 15 1.4k
F.B. Jolicoeur Canada 25 1.4k 1.6× 949 1.9× 281 1.2× 128 0.6× 47 0.3× 86 1.8k
Meredith M. Garcia United States 20 805 0.9× 464 1.0× 154 0.6× 254 1.1× 82 0.5× 38 1.2k
S J Peroutka United States 15 712 0.8× 463 0.9× 342 1.4× 71 0.3× 133 0.8× 17 1.3k
Valérie Bertaina‐Anglade France 14 412 0.5× 427 0.9× 120 0.5× 355 1.6× 73 0.4× 20 1.2k
L. G. Sharpe United States 16 609 0.7× 407 0.8× 201 0.8× 152 0.7× 53 0.3× 28 1.1k
Kumatoshi Ishihara Japan 22 937 1.1× 548 1.1× 153 0.6× 159 0.7× 111 0.7× 68 1.4k
Antonio Luchicchi Netherlands 22 888 1.0× 545 1.1× 227 0.9× 332 1.5× 503 3.0× 35 1.6k
T. Kubo Japan 24 542 0.6× 406 0.8× 281 1.2× 151 0.7× 61 0.4× 67 1.3k
Maureen V. Martin United States 16 425 0.5× 733 1.5× 473 2.0× 182 0.8× 144 0.9× 22 1.7k

Countries citing papers authored by Thierry Jolas

Since Specialization
Citations

This map shows the geographic impact of Thierry Jolas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Jolas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Jolas more than expected).

Fields of papers citing papers by Thierry Jolas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Jolas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Jolas. The network helps show where Thierry Jolas may publish in the future.

Co-authorship network of co-authors of Thierry Jolas

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Jolas. A scholar is included among the top collaborators of Thierry Jolas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Jolas. Thierry Jolas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jolas, Thierry, et al.. (2022). 0756 Preclinical Pharmacology of Solriamfetol: Potential Mechanisms for Wake Promotion. SLEEP. 45(Supplement_1). A329–A329. 3 indexed citations
2.
Jolas, Thierry, et al.. (2011). The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism. Pulmonary Pharmacology & Therapeutics. 25(1). 55–61. 44 indexed citations
3.
Horvat, Štefica, et al.. (2010). Synthesis, characterization and in vitro pharmacology of novel pregabalin derivatives. European Journal of Medicinal Chemistry. 45(4). 1447–1452. 5 indexed citations
4.
Jolas, Thierry, et al.. (2009). Differential effects of dopamine agonists at D2S and 5HT2B receptors. 19(9). 3183–92. 2 indexed citations
5.
Waterbury, L. David, et al.. (2006). Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Current Medical Research and Opinion. 22(6). 1133–1140. 88 indexed citations
6.
Jolas, Thierry. (2002). Long-Term Potentiation Is Increased in the CA1 Area of the Hippocampus of APPswe/ind CRND8 Mice. Neurobiology of Disease. 11(3). 394–409. 76 indexed citations
7.
Liu, Rongjian, Thierry Jolas, & George K. Aghajanian. (2000). Serotonin 5-HT2 receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus. Brain Research. 873(1). 34–45. 165 indexed citations
8.
Jolas, Thierry, et al.. (2000). Dual control of dorsal raphe serotonergic neurons by GABAB receptors. Electrophysiological and microdialysis studies. Synapse. 36(1). 21–21. 3 indexed citations
9.
Jolas, Thierry, Eric J. Nestler, & George K. Aghajanian. (1999). Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: association with an up-regulation of the cyclic AMP pathway. Neuroscience. 95(2). 433–443. 88 indexed citations
10.
Jolas, Thierry & George K. Aghajanian. (1997). Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Research. 755(2). 229–245. 151 indexed citations
11.
Jolas, Thierry & George K. Aghajanian. (1997). Neurotensin and the serotonergic system. Progress in Neurobiology. 52(6). 455–468. 43 indexed citations
12.
Jolas, Thierry & George K. Aghajanian. (1996). Neurotensin Excitation of Serotonergic Neurons in the Dorsal Raphe Nucleus of the Rat In Vitro. European Journal of Neuroscience. 8(1). 153–161. 44 indexed citations
13.
Jolas, Thierry, et al.. (1996). Reduced inhibitory potency of serotonin reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep. Biological Psychiatry. 40(10). 1000–1007. 31 indexed citations
14.
Haj‐Dahmane, Samir, Thierry Jolas, Anne‐Marie Laporte, et al.. (1994). Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat. European Journal of Pharmacology. 255(1-3). 185–196. 19 indexed citations
15.
Jolas, Thierry, et al.. (1994). Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat. Neuropharmacology. 33(8). 1017–1025. 22 indexed citations
16.
Jolas, Thierry, Samir Haj‐Dahmane, Emma J. Kidd, et al.. (1994). Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.. Journal of Pharmacology and Experimental Therapeutics. 268(3). 1432–1443. 102 indexed citations
17.
Jolas, Thierry, Samir Haj‐Dahmane, Laurence Lanfumey, et al.. (1993). (?)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain. Naunyn-Schmiedeberg s Archives of Pharmacology. 347(5). 453–463. 59 indexed citations
18.
19.
Adrien, J., Laurence Lanfumey, Samir Haj‐Dahmane, et al.. (1992). Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat. Neuropharmacology. 31(6). 519–529. 32 indexed citations
20.
Hamon, M., Laurence Lanfumey, Samir Haj‐Dahmane, et al.. (1991). Adaptation of central 5-HT1A receptors after chronic antidepressant treatment in rats. ORCA Online Research @Cardiff. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B B Wolfe Breakdown of academic impact, for papers by F.B. Jolicoeur Breakdown of academic impact, for papers by Meredith M. Garcia Breakdown of academic impact, for papers by S J Peroutka Breakdown of academic impact, for papers by Valérie Bertaina‐Anglade Breakdown of academic impact, for papers by L. G. Sharpe Breakdown of academic impact, for papers by Kumatoshi Ishihara Breakdown of academic impact, for papers by Antonio Luchicchi Breakdown of academic impact, for papers by T. Kubo Breakdown of academic impact, for papers by Maureen V. Martin
Rankless by CCL
2026